Scinai Immunotherapeutics (SCNI) Net Shares Issued and Repurchased (2021 - 2025)

Scinai Immunotherapeutics has disclosed Net Shares Issued and Repurchased across 4 years of filings, most recently posting $413.2 million for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased changed N/A year-over-year to $413.2 million; the TTM figure through Dec 2025 stood at $413.2 million (changed N/A YoY), while the FY2025 annual figure was $413.2 million, changed N/A from the prior year.
• Net Shares Issued and Repurchased came in at $413.2 million for Q4 2025 at Scinai Immunotherapeutics, up from $97.5 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $413.2 million in Q4 2025 to a low of $28.9 million in Q4 2021.
• Average Net Shares Issued and Repurchased over 4 years is $142.1 million, with a median of $63.2 million recorded in 2022.
• Year-over-year, Net Shares Issued and Repurchased climbed 0.1% in 2022 and surged 237.31% in 2023.
• Over 4 years, Net Shares Issued and Repurchased stood at $28.9 million in 2021, then rose by 0.1% to $28.9 million in 2022, then surged by 237.31% to $97.5 million in 2023, then jumped by 323.58% to $413.2 million in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $413.2 million in Q4 2025, $97.5 million in Q4 2023, and $28.9 million in Q4 2022.